Sharda Cropchem Ltd
Sharda Cropchem Ltd (SHARDACROP) last reported results for the quarter ended Jun 2026, with sales of ₹1,074 crore and net profit of ₹88 crore. The stock last traded at ₹726, a market capitalisation of ₹6,548 crore, on a P/E of 10.4. Over the past 52 weeks the stock has ranged between ₹698 and ₹1,298. Figures are as of 6 Oct 2026 and are not real time.
Sharda Cropchem Ltd share price and key metrics
- Current price
- ₹726
- Market cap
- ₹6,548 cr
- Stock P/E
- 10.4
- Book value
- ₹348
- ROE
- 23.2%
- ROCE
- 30.2%
- Dividend yield
- 2.07%
- 52w high / low
- 1298/698
Metrics as of 6 Oct 2026. Not real time.
Track Sharda Cropchem Ltd
Cruxal reads every Sharda Cropchem Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Sharda Cropchem Ltd growth and returns
- 10 Years
- 16%
- 5 Years
- 17%
- 3 Years
- 9%
- TTM
- 19%
- 10 Years
- 14%
- 5 Years
- 24%
- 3 Years
- 26%
- TTM
- 49%
- 10 Years
- 6%
- 5 Years
- 17%
- 3 Years
- 19%
- 1 Year
- -14%
- 10 Years
- 16%
- 5 Years
- 15%
- 3 Years
- 13%
- Last Year
- 23%
Sharda Cropchem Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,074 cr, up 9.0% from ₹985 cr a year earlier. Net profit was ₹88 cr, down 38.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 777 | 929 | 1,829 | 985 | 929 | 1,289 | 2,065 | 1,074 |
| Expenses | 687 | 815 | 1,525 | 770 | 796 | 1,048 | 1,578 | 888 |
| Operating profit | 90 | 115 | 303 | 215 | 133 | 241 | 487 | 186 |
| OPM % | 12% | 12% | 17% | 22% | 14% | 19% | 24% | 17% |
| Other income | 25 | 1 | 25 | 32 | 29 | 21 | 22 | 35 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| Depreciation | 69 | 69 | 72 | 78 | 76 | 83 | 87 | 100 |
| Profit before tax | 46 | 46 | 256 | 169 | 86 | 179 | 422 | 118 |
| Tax % | 7% | 32% | 20% | 16% | 13% | 19% | 24% | 26% |
| Net profit | 42 | 31 | 204 | 143 | 74 | 145 | 319 | 88 |
| EPS (₹) | 4.70 | 3.45 | 22.56 | 15.83 | 8.24 | 16.09 | 35.32 | 9.76 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Sharda Cropchem Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,399 | 1,707 | 1,998 | 2,003 | 2,396 | 3,580 | 4,045 | 3,163 | 4,320 | 5,268 | 5,357 |
| Operating profit | 324 | 364 | 376 | 350 | 450 | 696 | 659 | 303 | 615 | 1,059 | 1,047 |
| OPM % | 23% | 21% | 19% | 17% | 19% | 19% | 16% | 10% | 14% | 20% | 20% |
| Net profit | 190 | 191 | 176 | 165 | 229 | 349 | 342 | 32 | 304 | 681 | 626 |
| EPS (₹) | 21.11 | 21.14 | 19.55 | 18.25 | 25.40 | 38.71 | 37.90 | 3.53 | 33.74 | 75.47 | 69.41 |
TTM is the trailing twelve months to the most recent quarter.
Sharda Cropchem Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
| Reserves | 870 | 1,045 | 1,194 | 1,313 | 1,524 | 1,822 | 2,142 | 2,147 | 2,410 | 3,046 |
| Borrowings | 0 | 170 | 0 | 0 | 81 | 47 | 3 | 18 | 8 | 0 |
| Other liabilities | 686 | 914 | 914 | 940 | 1,163 | 1,779 | 2,108 | 1,773 | 2,205 | 2,620 |
| Total liabilities | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
| Fixed assets | 210 | 226 | 372 | 416 | 544 | 592 | 668 | 708 | 750 | 989 |
| CWIP | 232 | 360 | 220 | 161 | 131 | 212 | 204 | 283 | 291 | 247 |
| Investments | 61 | 22 | 212 | 116 | 83 | 134 | 32 | 159 | 294 | 361 |
| Other assets | 1,143 | 1,611 | 1,394 | 1,650 | 2,099 | 2,800 | 3,439 | 2,878 | 3,377 | 4,159 |
| Total assets | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
As reported by the company. Total assets equal total liabilities by construction.
Sharda Cropchem Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 181 | 17 | 556 | 146 | 246 | 267 | 328 | 341 | 604 | 656 |
| Cash from investing | -104 | -160 | -351 | -59 | -282 | -205 | -112 | -393 | -496 | -445 |
| Cash from financing | -38 | 132 | -215 | -60 | 43 | -91 | -97 | -37 | -68 | -118 |
| Net cash flow | 40 | -11 | -11 | 27 | 8 | -29 | 120 | -89 | 40 | 93 |
| Free cash flow | 39 | -185 | 413 | -30 | 15 | 33 | 84 | 69 | 211 | 158 |
| CFO / operating profit | 73% | 27% | 169% | 60% | 68% | 49% | 60% | 129% | 103% | 68% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Sharda Cropchem Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 32% | 27% | 23% | 18% | 21% | 26% | 21% | 4% | 16% | 30% |
| Debtor days | 175 | 191 | 148 | 180 | 177 | 157 | 165 | 173 | 165 | 166 |
| Inventory days | 117 | 169 | 96 | 100 | 117 | 130 | 145 | 155 | 117 | 121 |
| Days payable | 186 | 202 | 167 | 180 | 180 | 172 | 176 | 144 | 158 | 162 |
| Cash conversion cycle | 106 | 158 | 77 | 100 | 114 | 115 | 134 | 184 | 124 | 125 |
| Working capital days | 99 | 94 | 71 | 101 | 94 | 88 | 97 | 128 | 92 | 102 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Sharda Cropchem Ltd shareholding pattern
Promoters held 74.82% at Jun 2026, broadly unchanged since Jun 2025. FIIs 3.12% and DIIs 9.18%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% |
| FIIs | 2.52% | 3.77% | 4.69% | 5.48% | 5.26% | 4.20% | 4.60% | 3.12% |
| DIIs | 12.77% | 10.07% | 10.28% | 9.38% | 9.26% | 9.95% | 9.70% | 9.18% |
| Public | 9.91% | 11.33% | 10.21% | 10.33% | 10.65% | 11.02% | 10.88% | 12.88% |
| No. of shareholders | 48,353 | 58,717 | 51,187 | 62,030 | 67,290 | 65,567 | 61,155 | 63,572 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Sharda Cropchem Ltd corporate filings
- Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026Company Updatelow impact
- This is to inform that the trading window will be closed from 1st October, 2026 till 48 hours after the un-audited financial results are approved by the Board of Directors. The date of ....Insider Trading / SASTlow impact
- Sharda Cropchem Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Sharda Cropchem Ltd has issued an intimation regarding a scheduled meeting with analysts…
Read the full analysis - Sharda Cropchem Limited Announces Successful Conclusion of 23rd Annual General Meeting and Dividend ApprovalAGM/EGMlow impact
Cruxal's analysis: Sharda Cropchem Limited has successfully concluded its 23rd Annual General Meeting held…
Read the full analysis - Sharda Cropchem Limited concludes 23rd AGM; declares final dividend of INR 9.00 per share for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Sharda Cropchem Limited has successfully concluded its 23rd Annual General Meeting, where…
Read the full analysis - Sharda Cropchem Limited issues notice for transfer of unclaimed dividends and shares to IEPFCompany Updatelow impact
Cruxal's analysis: Sharda Cropchem Limited has issued a statutory notice regarding the mandatory transfer of…
Read the full analysis - Sharda Cropchem Reports Strong Q1 FY27 Operational Performance with 9% Revenue Growth and 25% EBITDA Growth, Despite Lower Reported PAT Due to Forex FluctuationsCompany Updatehigh impact
Cruxal's analysis: Sharda Cropchem Limited commenced FY27 on a strong footing, reporting a 9% year-on-year…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.